Page last updated: 2024-09-03

omega-n-methylarginine and Hepatopulmonary Syndrome

omega-n-methylarginine has been researched along with Hepatopulmonary Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Higenbottam, T; Maniscalco, M; Sofia, M1

Other Studies

1 other study(ies) available for omega-n-methylarginine and Hepatopulmonary Syndrome

ArticleYear
Effects of an NO-synthase inhibitor L-NMMA in the hepatopulmonary syndrome.
    Respiration; international review of thoracic diseases, 2001, Volume: 68, Issue:2

    Topics: Adult; Enzyme Inhibitors; Hepatopulmonary Syndrome; Humans; Male; omega-N-Methylarginine

2001